Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 204,524 | 161,764 | 223,607 | 332,854 | 195,734 |
| Marketable Securities | 38,950 | 61,977 | 264,473 | 116,343 | 165,899 |
| Receivables | 339,653 | 358,076 | 292,970 | 247,192 | 261,243 |
| Inventories | 375,616 | 321,015 | 253,045 | 212,342 | 205,512 |
| Income taxes - deferred | 41,408 | 36,450 | 35,862 | 30,984 | 25,727 |
| TOTAL | $1,093,941 | $1,028,974 | $1,129,777 | $1,008,211 | $908,460 |
| Non-Current Assets | |||||
| PPE Net | 300,732 | 271,561 | 189,627 | 180,258 | 202,324 |
| Intangibles | 550,410 | 538,743 | 164,097 | 141,725 | 171,914 |
| Other Non-Current Assets | 92,181 | 132,316 | 112,667 | 96,388 | 88,920 |
| TOTAL | $943,323 | $942,620 | $466,391 | $418,371 | $463,158 |
| Total Assets | $2,037,264 | $1,971,594 | $1,596,168 | $1,426,582 | $1,371,618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 10,997 | 503 | 391 | 402 |
| Accounts payable and accrued liabilities | 117,982 | 96,470 | 83,411 | 72,950 | 71,194 |
| Accrued Expenses | 119,420 | 121,255 | 92,101 | 81,076 | 79,061 |
| Other current liabilities | 98,290 | 106,708 | 77,949 | 55,822 | 50,511 |
| TOTAL | $418,034 | $414,168 | $319,533 | $319,243 | $315,375 |
| Non-Current Liabilities | |||||
| Long Term Debt | 445,979 | 441,805 | 425,625 | 425,687 | 425,979 |
| aiOther Non-Current Liabilities | 51,287 | 91,415 | 23,960 | 21,397 | 28,988 |
| TOTAL | $548,590 | $585,736 | $457,097 | $449,365 | $459,355 |
| Total Liabilities | $966,624 | $999,904 | $776,630 | $768,608 | $774,730 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,320 | 26,968 | 26,614 | 26,286 | 25,891 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 851,577 | 762,067 | 674,070 | 570,807 | 489,254 |
| Other shareholders' equity | 94,659 | 110,991 | 67,235 | 27,052 | 58,003 |
| TOTAL | $1,070,640 | $971,690 | $819,538 | $657,974 | $596,888 |
| Total Liabilities And Equity | $2,037,264 | $1,971,594 | $1,596,168 | $1,426,582 | $1,371,618 |